Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.
暂无分享,去创建一个
Arthur N. L. Chiu | P. Madureira | D. Waisman | R. Hill | Andrew M. Leidal | Patrick Lee | L. Gillis | Haley K Cochrane | Haley K Cochrane
[1] I. Roninson,et al. p21 (CDKN1A) is a Negative Regulator of p53 Stability , 2007, Cell cycle.
[2] C. Prives,et al. p53-Dependent p21 mRNA Elongation Is Impaired when DNA Replication Is Stalled , 2006, Molecular and Cellular Biology.
[3] Bo Xu,et al. ATR regulates hexavalent chromium-induced S-phase checkpoint through phosphorylation of SMC1. , 2006, Mutation research.
[4] D. Green,et al. Cytoplasmic p53: Bax and Forward , 2004, Cell cycle.
[5] Martin Schuler,et al. Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.
[6] R. Fotedar,et al. Role of p21WAF1 in the Cellular Response to UV , 2004, Cell cycle.
[7] S. Patierno,et al. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. , 2003, Mutation research.
[8] S. Patierno,et al. Chromium (VI) Activates Ataxia Telangiectasia Mutated (ATM) Protein , 2003, The Journal of Biological Chemistry.
[9] D. Green,et al. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation , 2003, Cell Death and Differentiation.
[10] W. El-Deiry,et al. Tissue-specific induction of p53 targets in vivo. , 2002, Cancer research.
[11] S. Patierno,et al. Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. , 2002, DNA repair.
[12] Ying Li,et al. AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival* , 2002, The Journal of Biological Chemistry.
[13] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[14] R. Iggo,et al. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[16] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[17] K. Kinzler,et al. Role of BAX in the apoptotic response to anticancer agents. , 2000, Science.
[18] K. Kinzler,et al. Cooperative effects of genes controlling the G(2)/M checkpoint. , 2000, Genes & development.
[19] W. El-Deiry,et al. p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. , 2000, Biochemical and biophysical research communications.
[20] M. Miura,et al. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21 , 1999, Oncogene.
[21] K. Kinzler,et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.
[22] M. Miura,et al. Resistance to Fas-mediated apoptosis: activation of Caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP , 1998, Oncogene.
[23] R. Bose,et al. Mechanisms of DNA damage by chromium(V) carcinogens. , 1998, Nucleic acids research.
[24] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[25] A. Gartel,et al. p21—Negative Regulator of the Cell Cycle , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[26] K. Kinzler,et al. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. , 1995, Cancer research.
[27] L. J. Maher,et al. DNA bending by asymmetric phosphate neutralization. , 1994, Science.
[28] S. Patierno,et al. Dna polymerase arrest by adducted trivalent chromium , 1994, Molecular carcinogenesis.
[29] A. Zhitkovich,et al. Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. , 1992, Carcinogenesis.
[30] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[31] P. Elias,et al. Human epidermal proteolipids: isolation, partial characterization, and subcellular localization. , 1988, The Journal of investigative dermatology.
[32] S. Patierno,et al. Transcriptional inhibition by carcinogenic chromate: Relationship to DNA damage , 1992, Molecular carcinogenesis.